Clal Insurance’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-292,000
| Closed | -$2.97M | – | 159 |
|
|
2020
Q3 | $2.97M | Hold |
292,000
| – | – | 0.05% | 93 |
|
|
2020
Q2 | $4.35M | Hold |
292,000
| – | – | 0.09% | 89 |
|
|
2020
Q1 | $3.56M | Buy |
292,000
+287,378
| +6,218% | +$3.5M | 0.09% | 81 |
|
|
2019
Q4 | $292K | Sell |
4,622
-287,378
| -98% | -$18.2M | 0.31% | 62 |
|
|
2019
Q3 | $3.59M | Sell |
292,000
-16,000
| -5% | -$196K | 0.09% | 77 |
|
|
2019
Q2 | $4.07M | Buy |
+308,000
| New | +$4.07M | 0.09% | 70 |
|